Taken together, these reports suggest that IL-11 is capable of ameliorating CNS autoimmune inflammation and further raise the possibility that this cytokine could be an immune effector of IVIg in the amelioration of EAE and MS. This evidence concerns the gene IL11 and myeloid sarcoma.